Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) EBT Margin (2009 - 2026)

Updated

Immucell (ICCC) posted EBT Margin of 11.63% for Q3 2026, up 14.09 percentage points from -2.46% a year earlier but down 14.54 percentage points from the prior quarter.

Analysis

Immucell (ICCC) EBT Margin (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBT Margin at Immucell was 5.79%, down 2.63 percentage points year-over-year; for FY2025, it was -3.72%, up 4.38 percentage points from FY2024.

  • Annual EBT Margin shows a five-year change of +3.01 percentage points (FY2020 to FY2025).
  • In prior years, Immucell's EBT Margin was -8.10% in FY2024 (+24.92 pp), -33.02% in FY2023 (-19.64 pp), -13.39% in FY2022 (-13.03 pp) and -0.36% in FY2021 (+6.37 pp).
  • Quarterly EBT Margin has run from a low of -67.13% in Q1 2023 to a high of 26.17% in Q2 2026 over five years.
  • On a year-over-year basis, EBT Margin has increased in each of the last three quarters, with an average year-over-year change of +8.32 percentage points over the last seven quarters.
  • The strongest year-over-year quarter for EBT Margin in the past five years was Q1 2024, with a gain of 61.11 percentage points; the weakest was Q1 2023, with a drop of 75.70 percentage points.
  • According to Business Quant data, EBT Margin for the three prior quarters was 26.17% (Q2 2026), 18.87% (Q1 2026) and -37.32% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 0.13%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 27.75%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 30.74%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 26.27%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 45.21%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.90%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 20.41%
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 11.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.63%
Jun 30, 2026 26.17%
Mar 31, 2026 18.87%
Dec 31, 2025 -37.32%
Sep 30, 2025 -2.46%
Jun 30, 2025 7.82%
Mar 31, 2025 17.96%
Dec 31, 2024 6.72%
Sep 30, 2024 -11.65%
Jun 30, 2024 -27.96%
Mar 31, 2024 -6.01%
Sep 30, 2023 -17.41%
Jun 30, 2023 -39.01%
Mar 31, 2023 -67.13%
Dec 31, 2022 -42.61%
Sep 30, 2022 -13.58%
Jun 30, 2022 -17.69%
Mar 31, 2022 8.57%
Dec 31, 2021 1.38%
Sep 30, 2021 3.03%
API Access

Immucell EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY